Nang Kwang Chemical Pharmaceutical Co., Ltd. Announces 2025 Q4 Earnings Per Share of NT$2.42
Nang Kwang Chemical Pharmaceutical Co., Ltd. (Stock Code: 1752) reported its financial results for the fourth quarter of 2025. The company's operating revenue for the quarter was NT$2.162 billion, with a net profit after tax of NT$244 million, resulting in basic earnings per share of NT$2.42. The company belongs to the biotechnology and healthcare industry.
📋 Article Processing Timeline
- 📰 Published: December 1, 2025 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (3047h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:20 (16h 20m after Collected)
Company Code: 1752
Company Name: Nang Kwang Chemical Pharmaceutical Co., Ltd.
Industry: Biotechnology and Healthcare
Year/Quarter: 2025 Q4
Basic Earnings Per Share: NT$2.42
Operating Revenue: NT$2.162 billion
Net Profit After Tax: NT$244 million
Company Name: Nang Kwang Chemical Pharmaceutical Co., Ltd.
Industry: Biotechnology and Healthcare
Year/Quarter: 2025 Q4
Basic Earnings Per Share: NT$2.42
Operating Revenue: NT$2.162 billion
Net Profit After Tax: NT$244 million
FAQ
What is Nang Kwang Chemical Pharmaceutical's stock code?
Nang Kwang Chemical Pharmaceutical's stock code is 1752.
What were Nang Kwang Chemical Pharmaceutical's Q4 2025 financial results?
In Q4 2025, Nang Kwang Chemical Pharmaceutical reported operating revenue of NT$2.162 billion, net profit after tax of NT$244 million, and basic earnings per share of NT$2.42.
What industry does Nang Kwang Chemical Pharmaceutical belong to?
Nang Kwang Chemical Pharmaceutical belongs to the biotechnology and healthcare industry.